Companies behind generic drugs are fighting a proposal requiring them to warn patients of all known health risks.
That's according to an article out of the Los Angeles Times.
The president of the generic pharmaceutical association, an industry trade group, told the paper the rule would raise health care costs and "create dangerous confusion" for doctors and patients.
The FDA is trying to close a legal loophole that requires brand name drugs to warn consumers, but not the generic drugs.
Copyright 2014 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.